Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950159-14-000400
Filing Date
2014-08-14
Accepted
2014-08-14 13:54:43
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 TENGIONC, INC. FORM 10-Q tengion10q.htm 10-Q 965436
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 15621
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 16172
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 6848
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 8299
  Complete submission text file 0000950159-14-000400.txt   6929370

Data Files

Seq Description Document Type Size
6 tngn-20140630.xml EX-101.INS 1133053
7 tngn-20140630.xsd EX-101.SCH 47202
8 tngn-20140630_cal.xml EX-101.CAL 36218
9 tngn-20140630_def.xml EX-101.DEF 195623
10 tngn-20140630_lab.xml EX-101.LAB 607739
11 tngn-20140630_pre.xml EX-101.PRE 328807
Mailing Address 3929 WESTPOINT BLVD. SUITE G WINSTON-SALEM NC 27103
Business Address 3929 WESTPOINT BLVD. SUITE G WINSTON-SALEM NC 27103 336-722-5855
TENGION INC (Filer) CIK: 0001296391 (see all company filings)

EIN.: 200214813 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34688 | Film No.: 141041393
SIC: 2836 Biological Products, (No Diagnostic Substances)